TY - JOUR
T1 - Reconciliation of classification systems defining molecular subtypes of colorectal cancer
T2 - Interrelationships and clinical implications
AU - Sadanandam, Anguraj
AU - Wang, Xin
AU - De Sousa E Melo, Felipe
AU - Gray, Joe W.
AU - Vermeulen, Louis
AU - Hanahan, Douglas
AU - Medema, Jan Paul
PY - 2014/2/1
Y1 - 2014/2/1
N2 - Recently we published two independent studies describing novel gene expression-based classifications of colorectal cancer (CRC). Notably, each study stratified CRC into a different number of subtypes: one reported 3 subtypes, whereas the second highlighted 5. Given that each ascribed clinical significance, distinctive biology, and therapeutic prognosis to the different subtypes, we sought to reconcile this apparent incongruity in subtype stratification of CRC, and to interrelate the results. To do so, we each evaluated the other's data sets and analytical methods and discovered that the subtypes and their classifiers are, in fact, clearly related to each other; indeed, the 5 subtype outcomes can be coalesced into the same three. In addition to presenting this clarification, we briefly discuss how both classification methods can be viewed within the broader literature on CRC subtypes, and potentially applied. © 2014 Landes Bioscience.
AB - Recently we published two independent studies describing novel gene expression-based classifications of colorectal cancer (CRC). Notably, each study stratified CRC into a different number of subtypes: one reported 3 subtypes, whereas the second highlighted 5. Given that each ascribed clinical significance, distinctive biology, and therapeutic prognosis to the different subtypes, we sought to reconcile this apparent incongruity in subtype stratification of CRC, and to interrelate the results. To do so, we each evaluated the other's data sets and analytical methods and discovered that the subtypes and their classifiers are, in fact, clearly related to each other; indeed, the 5 subtype outcomes can be coalesced into the same three. In addition to presenting this clarification, we briefly discuss how both classification methods can be viewed within the broader literature on CRC subtypes, and potentially applied. © 2014 Landes Bioscience.
KW - Cancer subtypes
KW - Cetuximab
KW - CIMP
KW - Colorectal cancer
KW - Consensus clustering
KW - MSI
KW - Serrated pathway
KW - Therapy resistance
UR - http://www.scopus.com/inward/record.url?scp=84896856425&partnerID=8YFLogxK
UR - https://www.scopus.com/record/pubmetrics.uri?eid=2-s2.0-84896856425&origin=recordpage
U2 - 10.4161/cc.27769
DO - 10.4161/cc.27769
M3 - RGC 21 - Publication in refereed journal
C2 - 24406433
SN - 1538-4101
VL - 13
SP - 353
EP - 357
JO - Cell Cycle
JF - Cell Cycle
IS - 3
ER -